Literature DB >> 2171530

Modification of the inhibitory effects of CCl4 on phospholipid and protein biosynthesis by prostacyclin.

A Divald1, A Jeney, J O Nagy, F Timár, K Lapis.   

Abstract

CCl4 induced cellular injury and its modification by prostacyclin (PGI2) was studied in cultured rat hepatocytes. Biosynthesis of both intracellular and serum proteins and that of phospholipids decreased upon CCl4 treatments (IC50 7.0, 2.5 and 3.2 mM, respectively). After 1 hr exposure of the cells to CCl4, the reductions in the biosynthesis increased further with time. PGI2 treatments (10(-5)-10(-9) M) of the hepatocytes subsequent to CCl4 poisoning resulted in partial recovery from the cell injury evaluated at the fifth hour of the experiment. Optimal effects of PGI2 were found at a concentration of 10(-7)-10(-8) M, while higher and lower concentrations offered less protection. Upon the addition of CCl4 a higher catabolic rate of PIP2 and an increased formation of inositol phosphates were observed. This alteration was shown to precede the defects in the labelling of the major phospholipid components. Furthermore, these changes were circumvented in the presence of PGI2. Thus, PIP2 metabolism appears to be a critical process in the mechanism of this type of cellular injury and its protection by PGI2.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171530     DOI: 10.1016/0006-2952(90)90443-o

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

1.  Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis.

Authors:  Roberto Gabriel Pozner; Soledad Negrotto; Lina Paola D'Atri; Mónica Lidia Kotler; María Angela Lazzari; Ricardo Martin Gomez; Mirta Schattner
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

2.  Modification of Acute and Chronic Liver Damage by Thiazolidine Compounds.

Authors:  András Divald; Zoltán Györgydeák; Ferenc Tímár; Attila Zalatnai; Rezsô Bognár; Gábor Horváth; Károly Lapis; András Jeney
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.